BioSig Technologies, Inc. Stock

Equities

BSGM

US09073N3008

Advanced Medical Equipment & Technology

Delayed OTC Markets 03:59:57 2024-06-13 pm EDT 5-day change 1st Jan Change
0.395 USD +51.92% Intraday chart for BioSig Technologies, Inc. -80.45% -91.68%
Sales 2024 * - Sales 2025 * 500K Capitalization 5.58M
Net income 2024 * -7M Net income 2025 * -11M EV / Sales 2024 * -
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 11.2 x
P/E ratio 2024 *
-0.65 x
P/E ratio 2025 *
-0.44 x
Employees 4
Yield 2024 *
-
Yield 2025 *
-
Free-Float 92.72%
More Fundamentals * Assessed data
Dynamic Chart
1 day+51.92%
1 week-80.45%
Current month-80.35%
1 month-71.99%
3 months-26.99%
6 months-87.65%
Current year-91.68%
More quotes
1 week
0.20
Extreme 0.201
1.90
1 month
0.20
Extreme 0.201
2.57
Current year
0.20
Extreme 0.201
4.75
1 year
0.20
Extreme 0.201
15.50
3 years
0.20
Extreme 0.201
45.80
5 years
0.20
Extreme 0.201
124.30
10 years
0.20
Extreme 0.201
124.30
More quotes
Managers TitleAgeSince
Chief Administrative Officer 51 09-02-23
Chief Tech/Sci/R&D Officer 74 09-02-23
Director/Board Member 58 22-04-27
Members of the board TitleAgeSince
Chief Tech/Sci/R&D Officer 74 09-02-23
Director/Board Member 58 22-04-27
Director/Board Member - May. 02
More insiders
Date Price Change Volume
24-06-13 0.395 +51.92% 1,348,649
24-06-12 0.26 -44.68% 1,669,239
24-06-11 0.47 -72.19% 3,330,423
24-06-10 1.69 -9.38% 105,608
24-06-07 1.865 -7.67% 75,049

Delayed Quote OTC Markets, June 13, 2024 at 03:59 pm EDT

More quotes
BioSig Technologies, Inc. is a medical technology company focused on deciphering the body’s electrical signals, starting with heart rhythms. The Company’s product, the PURE EP Platform, a non-invasive class II device, provides real-time signal visualization allowing physicians to perform highly targeted cardiac ablation procedures. Integrating with existing systems in the EP lab, PURE EP is designed to pinpoint even the complex signals to maximize procedural success and efficiency. The PURE EP System is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures, such as environmental lab noise from other equipment, signal saturation, slow signal recovery, and inaccurate display of fractionated potentials. PURE EP is a signal processing platform that combines advanced hardware and software to address known challenges associated to signal acquisition, to enable electrophysiologists to see more signals and analyze them in real-time.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.395 USD
Average target price
6 USD
Spread / Average Target
+1,418.99%
Consensus